Nacreon

About Nacreon

Peptide science,
put to work.

Nacreon is a research and development company focused on peptides and peptide-adjacent technologies. We start with practical problems, develop technologies through chemistry and advanced manufacturing, and bring that work to partners through licensing.

Our first focus is compound delivery and stability. Our first technology is Rapid Ions®.

Born in Protixa’s R&D.
Built to go further.

Protixa is a North American peptide development and manufacturing company. Nacreon grew out of its research and development. That work pointed to opportunities beyond Protixa’s own manufacturing business: technologies that other brands and manufacturers could build into their products.

Nacreon was created to pursue those opportunities. A separate company gives the research a path from development to licensing, with room to work across supplements, nutraceuticals, and pharmaceuticals.

From problem to product

01 / THE PROBLEM

Start where peptides fall short.

Peptide delivery often relies on needles. Many peptides are fragile and require controlled storage and shipping. A promising molecule still needs a practical way into a product. Those are the problems we start with.

02 / THE SCIENCE

Solve through research and formulation.

Rapid Ions® puts chemistry and advanced manufacturing to work on delivery and stability. Our research focuses on the formulation around the peptide, with the goal of enabling alternatives to needle delivery and less demanding storage conditions. The research follows the needs of each peptide, formulation and application.

03 / THE MARKET

Give the technology a path to market.

We license technologies to brands and manufacturers with products to build. Together, we define the development work, the evidence needed for the application, and the terms for using the technology.